Vaccine comprising recombinant feline leukemia antigen and saponin adjuvant
US5352449A · kind A · utility
20Cited by
14References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 14, 1992 |
| Grant date | Oct 4, 1994 |
| Priority date | — |
| Expiry date | Apr 14, 2012 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S424/819
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to antigenic preparations useful for inducing the production of antibodies in a cat which will bind to epitopes on feline leukemia virus. Also disclosed are immunogenic compositions and methods for immunizing a cat to enable the production of antibodies to feline leukemia virus.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.